Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on plasma lipids and lipoproteins, coagulation factors, and carbohydrate metabolism
- 1 July 2001
- journal article
- clinical trial
- Published by Elsevier in Fertility and Sterility
- Vol. 76 (1) , 13-24
- https://doi.org/10.1016/s0015-0282(01)01829-5
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Endometrial safety with lower doses of conjugated equine estrogens (CEE) and medroxyprogesterone acetate (MPA).Fertility and Sterility, 2001
- Effects of Estrogen Replacement on the Progression of Coronary-Artery AtherosclerosisNew England Journal of Medicine, 2000
- Determinants of long-term hormone replacement therapy and reasons for early discontinuationObstetrics & Gynecology, 2000
- Effect of Postmenopausal Hormone Therapy on Glucose and Insulin ConcentrationsDiabetes Care, 1998
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998
- Effects of Hormone-Replacement Therapy on Fibrinolysis in Postmenopausal WomenNew England Journal of Medicine, 1997
- Hormone replacement therapy with dydrogesterone and 17β‐oestradiol: effects on serum lipoproteins and glucose tolerance during 24 month follow upBJOG: An International Journal of Obstetrics and Gynaecology, 1997
- Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular DiseaseNew England Journal of Medicine, 1996
- Cholesterol and heart disease in older persons and women review of an NHLBI workshopAnnals of Epidemiology, 1992
- Metabolic risk factors for coronary heart disease in women: Perspective from the Framingham StudyAmerican Heart Journal, 1987